Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana project

Overview of attention for article published in Frontiers in immunology, August 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

So far, Altmetric has seen 13 X posts from 13 X users, with an upper bound of 207,316 followers.

RT @NedaaAlkhamis: دراسة: وجدت الدراسة ان نصف جرعة من AstraZeneca فعالة مثل الجرعة الكاملة ، ولكن أقل سمية. https://t.co/7F07eWRFvv

RT @NedaaAlkhamis: دراسة: وجدت الدراسة ان نصف جرعة من AstraZeneca فعالة مثل الجرعة الكاملة ، ولكن أقل سمية. https://t.co/7F07eWRFvv

دراسة: وجدت الدراسة ان نصف جرعة من AstraZeneca فعالة مثل الجرعة الكاملة ، ولكن أقل سمية. https://t.co/7F07eWRFvv

RT @Wejolyn: Ok… so the people that took the 💉’s could have been given a half dose instead and it was just as “efficient”? Well, good to kn…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.